AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant
- Sarah U. Morton1,2,3,
- Sanjay P. Prabhu4,
- Hart G.W. Lidov5,
- Jiahai Shi6,
- Irina Anselm7,
- Catherine A. Brownstein2,3,
- Matthew N. Bainbridge8,9,
- Alan H. Beggs2,3,
- Sara O. Vargas5 and
- Pankaj B. Agrawal1,2,3
- 1Division of Newborn Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 2Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 3The Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 4Department of Radiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 5Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 6Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR;
- 7Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA;
- 8Rady Children's Institute for Genomic Medicine, San Diego, California 92123, USA;
- 9Codified Genomics LLC, Houston, Texas 77004, USA
- Corresponding authors: sarah.morton{at}childrens.harvard.edu; pagrawal{at}enders.tch.harvard.edu
Abstract
Apoptosis-inducing factor mitochondrion-associated 1 (AIFM1), encoded by the gene AIFM1, has roles in electron transport, apoptosis, ferredoxin metabolism, reactive oxygen species generation, and immune system regulation. Here we describe a patient with a novel AIFM1 variant presenting unusually early in life with mitochondrial disease, rapid deterioration, and death. Autopsy, at the age of 4 mo, revealed features of mitochondrial encephalopathy, myopathy, and involvement of peripheral nerves with axonal degeneration. In addition, there was microvesicular steatosis in the liver, thymic noninvolution, follicular bronchiolitis, and pulmonary arterial medial hypertrophy. This report adds to the clinical and pathological spectrum of disease related to AIFM1 mutations and provides insights into the role of AIFM1 in cellular function.
- brain atrophy
- congenital lactic acidosis
- elevated brain lactate level by MRS
- infantile encephalopathy
- lethal infantile mitochondrial myopathy
- mitochondrial encephalopathy
- Received October 18, 2016.
- Accepted December 29, 2016.
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.
